TrialJournal of the International Association of Providers of AIDS Care

Feasibility, Fidelity, and Effectiveness of Administering Long-Acting Cabotegravir + Rilpivirine in Infusion Centers in the United States: Findings From the Phase 4 GLACIER Implementation Study.

Cassidy A Gutner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.